CAT vs PLX · P/E 48, rev $20.54B vs P/E 31, rev $53.4M
Caterpillar Inc (CAT) versus Protalix Biotherapeutics Inc (PLX) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported PLX revenue for 2024-12-31 was $53.4M. Net income was $2.9M. Revenue was down 18.5% from 2023-12-31 to 2024-12-31. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Not investment advice. Open the CAT and PLX stock pages for the full models.
Not investment advice.